Breaking News Instant updates and real-time market news.

KIDS

OrthoPediatrics

$30.74

-0.7 (-2.23%)

05:19
12/12/18
12/12
05:19
12/12/18
05:19

OrthoPediatrics capital raise positive signal for sales, says Piper Jaffray

Following yesterday's secondary offering, OrthoPediatrics has $65M of cash available, providing greater financial flexibility throughout 2019 regarding the timing and amount of instrument sets deployed, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst adds that with instrument set availability the largest "gating factor" for the company's growth, he views the capital raise as a positive signal for the company's sales outlook. He reiterates an Overweight rating on OrthoPediatrics and continues to believe that investors "should own this unique asset."

KIDS OrthoPediatrics
$30.74

-0.7 (-2.23%)

11/01/18
PIPR
11/01/18
NO CHANGE
Target $35
PIPR
Overweight
OrthoPediatrics should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien notes that OrthoPediatrics reported top-line growth of 28% in the quarter ahead of consensus and raised full-year guidance by 175bps at the midpoint. After normalizing some non-recurring professional fees, EPS was in-line with expectations, while EBITDA was ahead of his estimates. Overall, the analyst believes management continues to execute upon its growth strategy with consistent top-line momentum that makes it a unique name within orthopedics, and investors should take advantage of the weakness in the shares. He reiterates an Overweight rating on the stock, while raising his price target on the shares to $35 from $33.
10/19/18
PIPR
10/19/18
NO CHANGE
PIPR
Overweight
FDA approval closes gap in OrthoPediatrics spine franchise, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said OrthoPediatrics' announcement of FDA approval of their small stature scoliosis spine system was in-line with expectations from a timing perspective, adding that the system closes a gap in the company's spine franchise. O'Brien, who thinks the primary benefit of the new system should come during the primary scoliosis season in Q2 and Q3 of 2019, expects it will help sustain or even accelerate growth in this segment. The analyst keeps an Overweight rating on OrthoPediatrics shares, adding that he views the company as "truly unique."
08/09/18
PIPR
08/09/18
NO CHANGE
Target $33
PIPR
Overweight
OrthoPediatrics target raised to $33 on 'excellent' momentum at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for OrthoPediatrics to $33 from $30 saying the company's business momentum is "excellent" following its beat and raise Q2. OrthoPediatrics remains a unique name within orthopedics that investors should own, O'Brien tells investors in a research note. He keeps an Overweight rating on the name.
07/05/18
PIPR
07/05/18
NO CHANGE
Target $30
PIPR
Overweight
OrthoPediatrics price target raised to $30 from $24 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for OrthoPediatrics to $30 after hosting investor meetings with management. Operating in a "relatively niche but sizeable" $1.1B domestic market has allowed OrthoPediatrics to "fly under the radar as competitors have overlooked the many unmet medical needs in the space," O'Brien tells investors in a research note. He believes the company's key growth driver is deploying new instrument sets and notes it has already deployed $5.5M out of $10M in new sets this year. The analyst sees "many catalysts" for OrthoPediatrics and reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

WSM

Williams-Sonoma

$70.48

-0.88 (-1.23%)

21:33
11/12/19
11/12
21:33
11/12/19
21:33
Initiation
Williams-Sonoma initiated  »

Williams-Sonoma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$84.57

1.28 (1.54%)

21:31
11/12/19
11/12
21:31
11/12/19
21:31
Initiation
Wayfair initiated  »

Wayfair initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VFC

VF Corp.

$84.69

-1.7 (-1.97%)

21:28
11/12/19
11/12
21:28
11/12/19
21:28
Initiation
VF Corp. initiated  »

VF Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$30.85

0.295 (0.97%)

21:25
11/12/19
11/12
21:25
11/12/19
21:25
Initiation
Urban Outfitters initiated  »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

UAA

Under Armour

$17.29

-0.295 (-1.68%)

21:23
11/12/19
11/12
21:23
11/12/19
21:23
Initiation
Under Armour initiated at Barclays »

Under Armour initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$244.06

2.19 (0.91%)

21:19
11/12/19
11/12
21:19
11/12/19
21:19
Initiation
Ulta Beauty initiated at Barclays »

Ulta Beauty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TJX

TJX

$58.40

-0.14 (-0.24%)

21:15
11/12/19
11/12
21:15
11/12/19
21:15
Initiation
TJX initiated at Barclays »

TJX initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPR

Tapestry

$26.38

-0.295 (-1.11%)

21:12
11/12/19
11/12
21:12
11/12/19
21:12
Initiation
Tapestry initiated at Barclays »

Tapestry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AFL

Aflac

$53.97

-0.04 (-0.07%)

21:02
11/12/19
11/12
21:02
11/12/19
21:02
Hot Stocks
Aflac names Frederick Crawford new COO »

Aflac announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$110.97

-1.16 (-1.03%)

21:00
11/12/19
11/12
21:00
11/12/19
21:00
Initiation
Ross Stores initiated at Barclays »

Ross Stores initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

RL

Ralph Lauren

$111.44

-2.58 (-2.26%)

20:57
11/12/19
11/12
20:57
11/12/19
20:57
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$174.48

-0.18 (-0.10%)

20:56
11/12/19
11/12
20:56
11/12/19
20:56
Initiation
RH initiated at Barclays »

RH initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$96.91

0.14 (0.14%)

20:53
11/12/19
11/12
20:53
11/12/19
20:53
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

JWN

Nordstrom

$36.90

-0.52 (-1.39%)

20:51
11/12/19
11/12
20:51
11/12/19
20:51
Initiation
Nordstrom initiated at Barclays »

Nordstrom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

20:46
11/12/19
11/12
20:46
11/12/19
20:46
Initiation
Nike initiated at Barclays »

Nike initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$27.03

0.24 (0.90%)

20:43
11/12/19
11/12
20:43
11/12/19
20:43
Initiation
National Vision initiated at Barclays »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$17.53

0.02 (0.11%)

20:40
11/12/19
11/12
20:40
11/12/19
20:40
Initiation
L Brands initiated at Barclays »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BABA

Alibaba

$186.97

0.26 (0.14%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Periodicals
Alibaba gets approval to sell shares in Hong Kong, SCMP reports »

Alibaba has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ENR

Energizer

$42.01

-1.1 (-2.55%)

, SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ENR

Energizer

$42.01

-1.1 (-2.55%)

SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

SSYS

Stratasys

$20.74

0.04 (0.19%)

FVRR

Fiverr

$21.56

-0.47 (-2.13%)

MTOR

Meritor

$23.44

-0.25 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 21

    Nov

  • 09

    Dec

  • 12

    Dec

DDOG

Datadog

$34.40

0.89 (2.66%)

20:02
11/12/19
11/12
20:02
11/12/19
20:02
Hot Stocks
Datadog establishes Japanese subsidiary »

Datadog announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

, AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

19:40
11/12/19
11/12
19:40
11/12/19
19:40
Periodicals
Nike says to end retail pilot project w/ Amazon.com but continue AWS partnership 

Report from Bloomberg.

NKE

Nike

$89.51

-0.52 (-0.58%)

AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

, FJTSY

Fujitsu

$0.00

(0.00%)

19:34
11/12/19
11/12
19:34
11/12/19
19:34
Hot Stocks
HP Enterprise's Cray to partner with Fujitsu on 'supercomputer' technology »

Cray, a Hewlett Packard…

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

FJTSY

Fujitsu

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

IMAX

Imax

$21.26

-0.62 (-2.83%)

19:23
11/12/19
11/12
19:23
11/12/19
19:23
Hot Stocks
Imax names Edwin Tan as CEO of Imax China »

IMAX China announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

19:21
11/12/19
11/12
19:21
11/12/19
19:21
Periodicals
Tariffs on China imports become stumbling block to trade pact, WSJ says »

Tariffs are emerging as…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.67

-0.138 (-17.08%)

19:19
11/12/19
11/12
19:19
11/12/19
19:19
Hot Stocks
Chesapeake CEO says 'strongly' believes in current capital program »

November 12, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.